Abstract
There is limited information on the effect of age on the transmission of SARS-CoV-2 infection in different settings. We undertook a review of published data/studies on detection of SARS-CoV-2 infection in contacts of COVID-19 cases, as well as serological studies, and studies of infections in the school setting to examine those issues. Those sources suggest significantly lower susceptibility to infection for children aged under 10 years compared to adults, for elevated susceptibility to infection in adults aged over 60y, and for the risk of SARS-CoV-2 infection associated with sleeping close to an infected individual. Those sources also suggest that younger adults (particularly those aged under 35y) often have high rates of SARS-CoV-2 infection in the community. Additionally, there is evidence of robust spread of SARS-CoV-2 in high schools, and more limited spread in primary schools. Some countries with relatively large class sizes in primary schools (e.g. Chile and Israel) reported sizeable outbreaks in some of those schools, though the amount of transmission occurring in these schools (vs. outside) is not clear from current reports. Nonetheless, these reports suggest that classroom crowding and other factors related to social distancing in classrooms/schools may play a role in the spread of SARS-CoV-2 in primary schools. Those findings should have implications for school openings in different age groups of children, and they suggest the need to better protect adults over the age of 60 during the community spread of SARS-CoV-2.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by Award Number U54GM088558 from the National Institute of General Medical Sciences (ML, EG). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of General Medical Sciences.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This is not a Human Subjects Research as it is based on existing publicly available, de-identified aggregate data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.